1. Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation
   Zeng Wang et al, 2023, Journal of Dermatological Treatment CrossRef
2. Cyclic AMP Response Element Modulator-α Suppresses PD-1 Expression and Promotes Effector CD4+ T Cells in Psoriasis
   Sigrun R. Hofmann et al, 2021, The Journal of Immunology CrossRef
3. PD-L1 Triggered by Binding eIF3I Contributes to the Amelioration of Diabetes-Associated Wound Healing Defects by Regulating IRS4
   Le Kuai et al, 2022, Journal of Investigative Dermatology CrossRef
4. REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
   Shangyi Wang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
5. Clinicoprognostic and Histopathological Features of Guttate and Plaque Psoriasis Based on PD-1 Expression
   Chang-Jin Jung et al, 2021, Journal of Clinical Medicine CrossRef
6. Polymorphisms of PDCD1 and COL9A1 Genes in Plaque, Palmoplantar and Arthropathic Psoriasis in Romanian Patients
   Doriana-Sorina Lupea-Chilom et al, 2024, Applied Sciences CrossRef
7. Role of co‑inhibitory molecules in the treatment of psoriasis (Review)
   Yue Yao et al, 2024, Experimental and Therapeutic Medicine CrossRef
8. The regulation of the PD-1/PD-L1 pathway in imiquimod-induced chronic psoriasis itch and itch sensitization in mouse
   Zhehao Xu et al, 2024, Molecular Pain CrossRef
9. Camrelizumab-Associated Psoriasis
   Hai-Zhen Hui et al, 2022, American Journal of Therapeutics CrossRef